{"id":"W4361026857","doi":"10.1016/s1470-2045(23)00005-0","title":"Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference","year":2023,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; Foundation Medicine; Genentech; National Institutes of Health; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Servier; Astellas Pharma; Eisai; Ben and Catherine Ivy Foundation; Puma Biotechnology; Boston Pharmaceuticals; Voyager Therapeutics; BeiGene; Deciphera Pharmaceuticals; Agios Pharmaceuticals; Ipsen; Five Prime Therapeutics; Sanofi; GW Pharmaceuticals; Karyopharm Therapeutics; GlaxoSmithKline; AstraZeneca; Novocure; Celldex Therapeutics; Pfizer; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Clinical trial; Drug development; Clinical Oncology; Oncology; Internal medicine; Drug; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05571816,0.001580533,0.007486574,0.003073582,0.0003799528,0.006057499,0.002869226,0.003794474,0.007392684],"category_scores_gemma":[0.05124287,0.0009995055,0.005339205,0.004494361,0.001217783,0.003990008,0.001738513,0.005901245,0.001842109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005243884,"about_ca_system_score_gemma":0.01126848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003006829,"about_ca_topic_score_gemma":0.008795435,"domain_scores_codex":[0.989141,0.006068217,0.001671619,0.0008100746,0.001924365,0.0003848063],"domain_scores_gemma":[0.9348325,0.05090237,0.005034964,0.0009370566,0.00679597,0.001497086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004158604,0.0001889453,0.0004072913,0.09030449,0.002746985,0.00006678887,0.0001165634,0.00116293,0.0008231897,0.007089513,0.0770856,0.8158491],"study_design_scores_gemma":[0.007692809,0.002032164,0.00360916,0.1150395,0.01219319,0.0003452663,0.0001358439,0.0009465571,0.000862139,0.009892409,0.8471205,0.0001304727],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002806264,0.9926528,0.0005554057,0.003731604,0.000891358,0.0002412142,0.0004156658,0.00003651298,0.00119495],"genre_scores_gemma":[0.003715577,0.984823,0.003118486,0.005877425,0.0007400279,0.0004800685,0.0004482367,0.00003823282,0.0007589729],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.05571816,"threshold_uncertainty_score":0.2946694,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6506715989117712,"score_gpt":0.5827464133019178,"score_spread":0.06792518560985339,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}